BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 15283234)

  • 21. Absence of phagocyte NADPH oxidase 2 leads to severe inflammatory response in lungs of mice infected with Coccidioides.
    Gonzalez A; Hung CY; Cole GT
    Microb Pathog; 2011 Dec; 51(6):432-41. PubMed ID: 21896326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole glucan particles as a vaccine against systemic coccidioidomycosis.
    Clemons KV; Antonysamy MA; Danielson ME; Michel KS; Martinez M; Chen V; Stevens DA
    J Med Microbiol; 2015 Oct; 64(10):1237-1243. PubMed ID: 26297127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective immunity in coccidioidomycosis.
    Cox RA; Magee DM
    Res Immunol; 1998; 149(4-5):417-28; discussion 506-7. PubMed ID: 9720959
    [No Abstract]   [Full Text] [Related]  

  • 24. Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis.
    Nguyen C; Barker BM; Hoover S; Nix DE; Ampel NM; Frelinger JA; Orbach MJ; Galgiani JN
    Clin Microbiol Rev; 2013 Jul; 26(3):505-25. PubMed ID: 23824371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune response of vaccinated and non-vaccinated mice to Coccidioides posadasii infection.
    Xue J; Hung CY; Yu JJ; Cole GT
    Vaccine; 2005 May; 23(27):3535-44. PubMed ID: 15855012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of signal sequence in vaccine-induced protection against experimental coccidioidomycosis.
    Jiang C; Magee DM; Ivey FD; Cox RA
    Infect Immun; 2002 Jul; 70(7):3539-45. PubMed ID: 12065493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction and evaluation of a novel recombinant T cell epitope-based vaccine against Coccidioidomycosis.
    Hurtgen BJ; Hung CY; Ostroff GR; Levitz SM; Cole GT
    Infect Immun; 2012 Nov; 80(11):3960-74. PubMed ID: 22949556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A recombinant beta-1,3-glucanosyltransferase homolog of Coccidioides posadasii protects mice against coccidioidomycosis.
    Delgado N; Xue J; Yu JJ; Hung CY; Cole GT
    Infect Immun; 2003 Jun; 71(6):3010-9. PubMed ID: 12761077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of vaccines for coccidioidomycosis.
    Levine HB; Pappagianis D; Cobb JM
    Mycopathol Mycol Appl; 1970; 41(1):177-85. PubMed ID: 4999877
    [No Abstract]   [Full Text] [Related]  

  • 30. Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice.
    Li K; Yu JJ; Hung CY; Lehmann PF; Cole GT
    Infect Immun; 2001 May; 69(5):2878-87. PubMed ID: 11292702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coccidioides immitis as a Select Agent of bioterrorism.
    Dixon DM
    J Appl Microbiol; 2001 Oct; 91(4):602-5. PubMed ID: 11576294
    [No Abstract]   [Full Text] [Related]  

  • 32. Maize-Produced Ag2 as a Subunit Vaccine for Valley Fever.
    Hayden CA; Hung CY; Zhang H; Negron A; Esquerra R; Ostroff G; Abraham A; Lopez AG; Gonzales JE; Howard JA
    J Infect Dis; 2019 Jul; 220(4):615-623. PubMed ID: 31184702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules.
    Zimmermann CR; Johnson SM; Martens GW; White AG; Zimmer BL; Pappagianis D
    Infect Immun; 1998 May; 66(5):2342-5. PubMed ID: 9573127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic cell-based vaccine against coccidioides infection.
    Awasthi S
    Ann N Y Acad Sci; 2007 Sep; 1111():269-74. PubMed ID: 17363430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of a potential vaccine for Coccidioides immitis.
    Barnato AE; Sanders GD; Owens DK
    Emerg Infect Dis; 2001; 7(5):797-806. PubMed ID: 11747691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coccidioidomycosis in the U.S. Military: a review.
    Crum-Cianflone NF
    Ann N Y Acad Sci; 2007 Sep; 1111():112-21. PubMed ID: 17435116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proline-rich vaccine candidate antigen of Coccidioides immitis: conservation among isolates and differential expression with spherule maturation.
    Peng T; Orsborn KI; Orbach MJ; Galgiani JN
    J Infect Dis; 1999 Feb; 179(2):518-21. PubMed ID: 9878042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendritic cell-based immunization induces Coccidioides Ag2/PRA-specific immune response.
    Awasthi S; Vilekar P; Conkleton A; Rahman N
    Vaccine; 2019 Mar; 37(12):1685-1691. PubMed ID: 30795939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in Host Innate Responses among Coccidioides Isolates in a Murine Model of Pulmonary Coccidioidomycosis.
    Lewis ER; David VR; Doyle AL; Rajabi K; Kiefer JA; Pirrotte P; Barker BM
    Eukaryot Cell; 2015 Oct; 14(10):1043-53. PubMed ID: 26275879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization of mice with induced mutants of Coccidioides immitis. I. Characterization of mutants and preliminary studies of their use as viable vaccines.
    Walch HA; Kalvoda A
    Sabouraudia; 1971 Nov; 9(3):173-84. PubMed ID: 5135085
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.